MLYS.OQ - Mineralys Therapeutics Inc
Mineralys Therapeutics Inc
Guggenheim Securities LLC

MLYS: Ph2 Explore-OSA Reading Out Imminently is Strategically Important, Offering Potential to Unlock OUS and Combo Optionality For Lorundrostat

公司
MLYS.OQ
日期
2026-03-02
分析师
Mr. Seamus Fernandez
页数
6
需要登录
请登录后购买研报或生成音频内容。